Suppr超能文献

UCSF 标准下肝切除术与肝移植治疗肝细胞癌的长期疗效比较。

Long-term outcomes after resection versus transplantation for hepatocellular carcinoma within UCSF criteria.

机构信息

Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Ann Surg Oncol. 2012 Mar;19(3):826-33. doi: 10.1245/s10434-011-1975-x. Epub 2011 Aug 31.

Abstract

PURPOSE

We compared the long-term outcomes of resection and transplantation for hepatocellular carcinoma (HCC) while satisfying the University of California at San Francisco criteria.

METHODS

HCC patients who underwent liver resection (n = 746) and transplantation (n = 54) between 2001 and 2007 were reviewed. Overall and disease-free survival rates were evaluated using the Kaplan-Meier estimator, and independent prognostic factors were determined using the Cox proportional regression model. The presence of cirrhosis was used to divide the patients into groups. The patients who received primary transplantation were further analyzed.

RESULTS

Nine years after surgery, the patients' overall survival was similar in the resection and transplantation groups (75.9 and 77.2%, respectively). Furthermore, the recurrence rate in the resection group was higher than that in the transplantation group (65 vs. 34.4%; adjusted hazard ratio, 3.27; range, 1.76-6.08), especially for cirrhosis patients (adjusted hazard ratio, 4.28; range, 2.14-8.56). The results suggested that noncirrhotic patients who underwent resection had a better survival advantage than primary liver transplant recipients did (adjusted hazard ratio, 0.46; range, 0.18-1.21). However, noncirrhotic patients had higher recurrence rates (59.2 vs. 15.8%; adjusted hazard ratio, 3.98; range, 1.26-12.58). Similar trends were noted in patients with hepatitis B virus infection and/or a single tumor.

CONCLUSIONS

Long-term survival rates after liver transplantation and resection were similar, but the latter was associated with a higher recurrence rate.

摘要

目的

我们比较了在符合旧金山加利福尼亚大学(UCSF)标准的情况下,肝切除术与肝移植术治疗肝细胞癌(HCC)的长期疗效。

方法

回顾了 2001 年至 2007 年间接受肝切除术(n=746)和肝移植术(n=54)的 HCC 患者。采用 Kaplan-Meier 估计法评估总生存率和无疾病生存率,采用 Cox 比例风险回归模型确定独立预后因素。根据是否存在肝硬化将患者分为两组。进一步分析接受原发性移植的患者。

结果

手术后 9 年,两组患者的总生存率相似(分别为 75.9%和 77.2%)。此外,肝切除组的复发率高于肝移植组(65%比 34.4%;调整后的危险比,3.27;范围,1.76-6.08),尤其是肝硬化患者(调整后的危险比,4.28;范围,2.14-8.56)。结果表明,与原发性肝移植受者相比,行切除术的非肝硬化患者具有更好的生存优势(调整后的危险比,0.46;范围,0.18-1.21)。然而,非肝硬化患者的复发率更高(59.2%比 15.8%;调整后的危险比,3.98;范围,1.26-12.58)。在乙型肝炎病毒感染和/或单个肿瘤患者中也观察到类似的趋势。

结论

肝移植和肝切除术后的长期生存率相似,但后者与更高的复发率相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验